WallStreetZenWallStreetZen

NASDAQ: AKLI
Akili Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their AKLI stock forecasts and price targets.

Forecast return on equity

Is AKLI forecast to generate an efficient return?
Company
-43.9%
Industry
1.02%
Market
43.56%
AKLI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AKLI forecast to generate an efficient return on assets?
Company
-32.72%
Industry
5.85%
AKLI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AKLI earnings per share forecast

What is AKLI's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$0.53
Avg 2 year Forecast
-$0.28

AKLI revenue forecast

What is AKLI's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$11.6M+497.33%
Avg 2 year Forecast
$17.7M+810.16%
AKLI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AKLI revenue growth forecast

How is AKLI forecast to perform vs Health Information Services companies and vs the US market?
Company
497.33%
Industry
8.84%
Market
12.31%
AKLI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AKLI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AKLI vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
AKLI$0.42N/AN/A
STRM$0.51N/AN/A
CCLD$2.29$3.50+52.84%Strong Buy
ONMD$1.20N/AN/A
AUGX$0.78N/AN/A

Akili Stock Forecast FAQ

What is AKLI's earnings growth forecast for 2024-2025?

(NASDAQ: AKLI) Akili's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 25.2%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.95%.

Akili's earnings in 2024 is -$48,545,000.On average, 1 Wall Street analyst forecast AKLI's earnings for 2024 to be -$41,719,419, with the lowest AKLI earnings forecast at -$41,719,419, and the highest AKLI earnings forecast at -$41,719,419.

In 2025, AKLI is forecast to generate -$22,040,448 in earnings, with the lowest earnings forecast at -$22,040,448 and the highest earnings forecast at -$22,040,448.

If you're new to stock investing, here's how to buy Akili stock.

What is AKLI's revenue growth forecast for 2024-2025?

(NASDAQ: AKLI) Akili's forecast annual revenue growth rate of 497.33% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 8.84%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.31%.

Akili's revenue in 2024 is $1,948,000.On average, 1 Wall Street analysts forecast AKLI's revenue for 2024 to be $915,938,038, with the lowest AKLI revenue forecast at $915,938,038, and the highest AKLI revenue forecast at $915,938,038.

In 2025, AKLI is forecast to generate $1,395,632,641 in revenue, with the lowest revenue forecast at $1,395,632,641 and the highest revenue forecast at $1,395,632,641.

What is AKLI's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: AKLI) forecast ROA is -32.72%, which is lower than the forecast US Health Information Services industry average of 5.85%.

What is AKLI's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: AKLI) Akili's current Earnings Per Share (EPS) is -$0.61. On average, analysts forecast that AKLI's EPS will be -$0.53 for 2024, with the lowest EPS forecast at -$0.53, and the highest EPS forecast at -$0.53. In 2025, AKLI's EPS is forecast to hit -$0.28 (min: -$0.28, max: -$0.28).

What is AKLI's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: AKLI) forecast ROE is -43.9%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.